Gavin, James R <br/><br/>
Moxifloxacin and glucose homeostasis: a pooled-analysis of the evidence from clinical and postmarketing studies.  [electronic resource] 

 -  Drug safety  2004 
 - 671-86 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0114-5916 
<br/><br/><label>Standard No.: </label>10.2165/00002018-200427090-00005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Bacterial Agents--adverse effects<br/>Aza Compounds--adverse effects<br/>Blood Glucose--analysis<br/>Clinical Trials, Phase II as Topic<br/>Clinical Trials, Phase III as Topic<br/>Diabetes Mellitus--blood<br/>Fluoroquinolones<br/>Glucose--metabolism<br/>Homeostasis<br/>Humans<br/>Hyperglycemia--chemically induced<br/>Hypoglycemia--chemically induced<br/>Male<br/>Moxifloxacin<br/>Product Surveillance, Postmarketing<br/>Quinolines--adverse effects<br/>Rats